Table 1 Epidemiological studies of the associated risk between dyslipidemia and venous thromboembolism (VTE)
From: The role of dyslipidemia and statins in venous thromboembolism
| Prevalence | |||||||
|---|---|---|---|---|---|---|---|
| of lipid | Odds | ||||||
| Mean age | % cases | risk factor | ratio | ||||
| No. cases/ | of cases | VTE | with situational | among | (95% CI) | ||
| Study [reference] | controls | (years) | type | risk factors* | Serum lipid risk factor(s) | cases (%) | for VTE |
| Goldhaber et al [7] | 280/112542 | 30–55 | PE | 55 | Self-reported elevated TC | 18 | 1.1 (0.7–1.5) |
| Kawasaki et al [8] | 109/109 | 50 | Leg DVT | 34 | TC > 5.7 mmol/L and TG > 1.7 mmol/L | 23 | 5.1 (2.0–13.0) |
| TC > 5.7 mmol/L and TG ≤ 1.7 mmol/L | 26 | 2.6 (1.2–5.3) | |||||
| Nowak-Gottl et al [10] | 186/186 | 5 | Any VTE | 60 | Lp(a) > 30 mg/dL | 42 | 7.2 (3.7–14.5) |
| von Depka et al [11] | 685/266 | 34 | Any VTE | 21 | Lp(a) > 10 mg/dL | 40 | 1.6 (1.2–2.2) |
| Lp(a) > 20 mg/dL | 25 | 2.2 (1.5–3.3) | |||||
| Lp(a) > 30 mg/dL | 20 | 3.2 (1.9–5.3) |